This UCSD-NHLBI Translational Cardiovascular Science and Medicine Training Program is designed to develop highly qualified Ph.D./Postdoctoral Fellows, and Physician/Scientists that have been training at the forefront of cardiovascular science and medicine. The Program incorporates several of the top molecular scientists in the La Jolla scientific community at our three neighboring Institutions, including The Salk Institute, Scripps Research Foundation, and the Burnham Institute. In every case, these scientists hold cross-appointments with UCSD, have a history of active participating in the IMM program and are currently collaborating with investigators at UCSD toward scientific and technological advances that will have a direct impact on our understanding of cardiovascular diseases. Thus, the Program will promote the cross-fertilization between Institutions and fields, while maintaining a strict focus on cardiovascular biology and medicine. In this manner, the Program will eventually allow future opportunities to translate new developments in molecular cardiovascular sciences into therapeutic and prognostic capabilities in clinical cardiology. Accordingly, the objectives are: 1) To identify, recruit, and training highly qualified, accomplished, and committed Ph.D. postdoctoral fellows, and M.D and combined degree M.D./Ph.D. fellows with a sincere interest in translational cardiovascular science and medicine; 2) To harness the strengths of the most advanced technologies to understand the mechanistic basis of key aspects of cardiovascular biology and disease; 3) To translate these fundamental findings into new therapeutic, diagnostic, and prognostic advances in the mainstream of clinical cardiology, by creating direct collaborations amongst clinical cardiovascular scientists, basic cardiovascular scientists, and existing scientific strengths in genetics, molecular/cellular biology, and bioengineering on the UCSD campus and within the La Jolla scientific community.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007770-15
Application #
7218704
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Scott, Jane
Project Start
1993-07-01
Project End
2009-12-31
Budget Start
2007-07-01
Budget End
2009-12-31
Support Year
15
Fiscal Year
2007
Total Cost
$432,807
Indirect Cost
Name
University of California San Diego
Department
Pharmacology
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Jensen, Paul N; Gronroos, Noelle N; Chen, Lin Y et al. (2014) Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol 64:531-8
Cho, Han; Zhao, Xuan; Hatori, Megumi et al. (2012) Regulation of circadian behaviour and metabolism by REV-ERB-? and REV-ERB-?. Nature 485:123-7
Barish, Grant D; Atkins, Annette R; Downes, Michael et al. (2008) PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis. Proc Natl Acad Sci U S A 105:4271-6
Kondo, Richard P; Anderson, Robert H; Kupershmidt, Sabina et al. (2003) Development of the cardiac conduction system as delineated by minK-lacZ. J Cardiovasc Electrophysiol 14:383-91
Chawla, A; Barak, Y; Nagy, L et al. (2001) PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7:48-52
Chawla, A; Boisvert, W A; Lee, C H et al. (2001) A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7:161-71
Guy, P M; Kenny, D A; Gill, G N (1999) The PDZ domain of the LIM protein enigma binds to beta-tropomyosin. Mol Biol Cell 10:1973-84
Kenny, D A; Jurata, L W; Saga, Y et al. (1998) Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis. Proc Natl Acad Sci U S A 95:11257-62
Ross, R S; Navankasattusas, S; Harvey, R P et al. (1996) An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac ventricular specificity and established an anterior-posterior gradient of expression. Development 122:1799-809
Saito, A; Yamazaki, H; Rader, K et al. (1996) Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis. Proc Natl Acad Sci U S A 93:8601-5